Etomidate (Mylan Institutional LLC)


Welcome to the PulseAid listing for the Etomidate drug offered from Mylan Institutional LLC. This General Anesthesia [PE],General Anesthetic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Institutional LLC
NON-PROPRIETARY NAME: etomidate
SUBSTANCE NAME: ETOMIDATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: General Anesthesia [PE],General Anesthetic [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-04-26
END MARKETING DATE: 0000-00-00


Etomidate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEtomidate from Mylan Institutional LLC
LABELER NAME: Mylan Institutional LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mg/mL)
START MARKETING DATE: 2013-04-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67457-183_1bf58b60-2972-4900-b2cd-300fb79edf7c
PRODUCT NDC: 67457-183
APPLICATION NUMBER: ANDA091297

Other ETOMIDATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.Etomidate
Athenex Pharmaceutical Division, LLC.Etomidate
AuroMedics Pharma LLCETOMIDATE
Cadila Healthcare LimitedETOMIDATE
General Injectables & Vaccines, IncAmidate
Gland Pharma LimitedEtomidate
Heritage Pharmaceuticals Inc.Etomidate
Hospira, Inc.AMIDATE
Mylan Institutional LLCEtomidate
Pfizer Laboratories Div Pfizer Inc.Etomidate
Sagent Pharmaceuticalsetomidate
West-Ward Pharmaceuticals CorpEtomidate
Zydus Pharmaceuticals (USA) Inc.etomidate